Skip to main content

Featured

Nerve Block Therapy Offers Hope for Migraine Sufferers

                           Calgary neurologist Dr. Serena Orr injecting a patient to help treat migraines.  Researchers in Calgary are spotlighting a promising treatment for people living with severe migraines: occipital nerve blocks . This approach involves injecting a small amount of anesthetic near the occipital nerves at the back of the head, which can interrupt pain signals and provide rapid relief. Neurologist Dr. Serena Orr of the University of Calgary has been at the forefront of this research, recommending updates to the American Headache Society’s guidelines for emergency departments. The new recommendations encourage doctors to consider nerve blocks as a frontline option for patients arriving with debilitating migraine attacks. Patients who have received the treatment report significant improvement. Some describe it as the first time they’ve been able to escape the crushing pain, nausea,...

article

New Cystic Fibrosis Drug Offers Hope, but Comes with a High Price

A new drug for cystic fibrosis, Trikafta, is providing significant hope for patients suffering from the genetic disorder. Trikafta has been shown to reduce hospital visits and improve overall lung function, offering patients a better quality of life. For those living with cystic fibrosis, which affects the respiratory and digestive systems, this advancement is nothing short of a breakthrough.

However, the cost of Trikafta is a major concern. Priced at around $300,000 per year, the drug is prohibitively expensive for many patients and their families. While some health programs and insurance plans may cover the cost, access to this life-changing medication remains a challenge.

As the debate over drug pricing and healthcare accessibility continues, the medical community and patient advocacy groups are calling for measures to ensure that Trikafta is available to all who need it, regardless of their financial situation.


Comments